Switching gears from Science to Business is necessary to pitch a successful Commercialization Plan as required in the Phase 2 SBIR. Learn how to meet the challenge and open the door to multi-million $ non-dilutive grants. We will cover the 7 required CP sections and tactical approaches to addressing each in impactful ways.
Registration: Free, but registration is required for Zoom access. Information on remote access (via Zoom) will be distributed to registrants by 10am on March 15.
Meet Your Speaker:
Elizabeth Anne Smith: Principal, Somax Consulting
PhD, Biochemistry and Molecular Biology, University of Chicago, Chicago, IL
MBA, Booth School of Business, Chicago, IL
BA, Chemistry, The College of Wooster, Wooster OH
Dr. Elizabeth Smith, has been working with start-up biotech companies since 1999 when she worked at the University of Chicago technology transfer office licensing bio-health innovations. She is the founder and owner of SoMax Consulting. Since 2013 she has provided corporate BD strategy and tactics for over 50 start-up companies developing drugs or molecular diagnostics and helped to secure over $15M in non-dilutive funding. In addition to consulting, she is part time VP of Partnering and Strategy for Fzata, Inc.